tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AMGN Stock Latest News

Amgen price target raised to $326 from $315 at UBS
The FlyAmgen price target raised to $326 from $315 at UBS
5h ago
AMGN
Amgen’s Phase 3 Study on Etelcalcetide: A Potential Game-Changer for Pediatric Kidney Disease
PremiumCompany Announcements
Amgen’s Phase 3 Study on Etelcalcetide: A Potential Game-Changer for Pediatric Kidney Disease
3d ago
AMGN
Amgen’s Phase 2 Asthma Study: A Potential Game-Changer for Rocatinlimab
PremiumCompany Announcements
Amgen’s Phase 2 Asthma Study: A Potential Game-Changer for Rocatinlimab
3d ago
AMGN
Amgen’s Promising Phase 3 Study: Maridebart Cafraglutide for Obesity in Type 2 Diabetes
PremiumCompany Announcements
Amgen’s Promising Phase 3 Study: Maridebart Cafraglutide for Obesity in Type 2 Diabetes
3d ago
AMGN
Amgen’s Romiplostim Study: A Potential Game-Changer for Chemotherapy Patients
PremiumCompany Announcements
Amgen’s Romiplostim Study: A Potential Game-Changer for Chemotherapy Patients
3d ago
AMGN
Amgen’s AMG 193 Study: A Potential Game-Changer in Thoracic Tumor Treatment
PremiumCompany AnnouncementsAmgen’s AMG 193 Study: A Potential Game-Changer in Thoracic Tumor Treatment
3d ago
AMGN
Amgen’s New Study on SCLC Treatment: A Potential Game Changer?
Premium
Company Announcements
Amgen’s New Study on SCLC Treatment: A Potential Game Changer?
3d ago
AMGN
Amgen’s New Study on ABP 234: A Potential Game-Changer in Lung Cancer Treatment
Premium
Company Announcements
Amgen’s New Study on ABP 234: A Potential Game-Changer in Lung Cancer Treatment
3d ago
AMGN
Amgen’s Xaluritamig Study: A Potential Game-Changer in Prostate Cancer Treatment?
PremiumCompany Announcements
Amgen’s Xaluritamig Study: A Potential Game-Changer in Prostate Cancer Treatment?
3d ago
AMGN
Amgen’s Avacopan Study: A Potential Game-Changer in Vasculitis Treatment
PremiumCompany Announcements
Amgen’s Avacopan Study: A Potential Game-Changer in Vasculitis Treatment
3d ago
AMGN
Amgen’s Promising Phase 3 Study on Metastatic Colorectal Cancer: A Potential Game-Changer
PremiumCompany Announcements
Amgen’s Promising Phase 3 Study on Metastatic Colorectal Cancer: A Potential Game-Changer
3d ago
AMGN
Amgen’s Promising Phase 3 Study on Dazodalibep for Sjögren’s Syndrome
PremiumCompany Announcements
Amgen’s Promising Phase 3 Study on Dazodalibep for Sjögren’s Syndrome
3d ago
AMGN
Amgen’s Phase 2 Study on HZN-1116: A Potential Breakthrough for Sjögren’s Syndrome
PremiumCompany AnnouncementsAmgen’s Phase 2 Study on HZN-1116: A Potential Breakthrough for Sjögren’s Syndrome
3d ago
AMGN
Amgen and Novartis’s Erenumab Study: A Potential Game-Changer in Pediatric Migraine Treatment
Premium
Company Announcements
Amgen and Novartis’s Erenumab Study: A Potential Game-Changer in Pediatric Migraine Treatment
3d ago
NVS
AMGN
Amgen’s New Study on ABP 692 vs. Ocrelizumab: A Potential Game Changer in MS Treatment
Premium
Company Announcements
Amgen’s New Study on ABP 692 vs. Ocrelizumab: A Potential Game Changer in MS Treatment
3d ago
AMGN
Amgen’s Promising Melanoma Study: A Potential Game-Changer?
PremiumCompany Announcements
Amgen’s Promising Melanoma Study: A Potential Game-Changer?
3d ago
AMGN
Amgen’s New Obesity Drug: A Potential Game-Changer?
PremiumCompany Announcements
Amgen’s New Obesity Drug: A Potential Game-Changer?
3d ago
AMGN
Amgen’s Tarlatamab Study: A New Hope in Small Cell Lung Cancer?
PremiumCompany Announcements
Amgen’s Tarlatamab Study: A New Hope in Small Cell Lung Cancer?
3d ago
AMGN
Amgen’s ABP 234 vs. Keytruda®: A New Frontier in Lung Cancer Treatment?
PremiumCompany Announcements
Amgen’s ABP 234 vs. Keytruda®: A New Frontier in Lung Cancer Treatment?
3d ago
AMGN
Amgen’s Phase 3 Study on Maridebart Cafraglutide: A Potential Game-Changer in Weight Management
PremiumCompany AnnouncementsAmgen’s Phase 3 Study on Maridebart Cafraglutide: A Potential Game-Changer in Weight Management
3d ago
AMGN
Amgen’s Phase 2a Study: A Potential Game-Changer in Autoimmune Disease Treatment
Premium
Company Announcements
Amgen’s Phase 2a Study: A Potential Game-Changer in Autoimmune Disease Treatment
4d ago
AMGN
Amgen’s AMG 732 Study: A Potential Game-Changer for Thyroid Eye Disease
Premium
Company Announcements
Amgen’s AMG 732 Study: A Potential Game-Changer for Thyroid Eye Disease
4d ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >